Illinois General Assembly - Bill Status for SB0101

Illinois General Assembly - Bill Status for SB0101

Home

Legislation & Laws

Senate

House

Site Map

Bills & Resolutions

Compiled Statutes

Legislative Reports

IL Constitution

Legislative Guide

Legislative Glossary

Search By Number
(example: HB0001)

Search By Keyword

Bill Status of SB0101 103rd General Assembly

Full Text Votes Witness Slips View All Actions Printer-Friendly Version

Short Description: INS-PEDIATRIC AUTOIMMUNE COVER

Senate Sponsors
Sen. Laura Fine - Laura Ellman and Paul Faraci

House Sponsors
(Rep. Jennifer Gong-Gershowitz and Janet Yang Rohr)

Last Action

Date	Chamber	Action
6/9/2023	Senate	Public Act . . . . . . . . . 103-0059

Statutes Amended In Order of Appearance

215 ILCS 5/356z.25

Synopsis As Introduced
Amends the Illinois Insurance Code. Provides that no group or individual policy of accident and health insurance or managed care plan shall deny or delay coverage for medically necessary treatment because the insured, enrollee, or beneficiary previously received any treatment, including the same or similar treatment, for pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections or pediatric acute onset neuropsychiatric syndrome, or because the insured, enrollee, or beneficiary has been diagnosed with or receives treatment for an otherwise diagnosed condition. Provides that coverage of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute onset neuropsychiatric syndrome shall adhere to the treatment recommendations developed by a medical professional consortium convened for the purposes of researching, identifying, and publishing best practice standards for diagnosis and treatment of such disorders or syndrome that are accessible for medical professionals and are based on evidence of positive patient outcomes. Provides that coverage for any form of medically necessary treatment shall not be limited over a lifetime of an insured, enrollee, or beneficiary, unless the patient is no longer benefiting from the treatment, or by policy period. Provides that nothing in the provisions prevents insurers from requesting treatment notes and anticipated duration of treatment and outcomes. Effective immediately.

Actions

Date	Chamber	Action
1/24/2023	Senate	Filed with Secretary by Sen. Laura Fine
1/24/2023	Senate	First Reading
1/24/2023	Senate	Referred to Assignments
1/30/2023	Senate	Added as Chief Co-Sponsor Sen. Laura Ellman
1/31/2023	Senate	Assigned to Insurance
2/8/2023	Senate	Do Pass Insurance; 010-000-000
2/8/2023	Senate	Placed on Calendar Order of 2nd Reading February 14, 2023
3/3/2023	Senate	Added as Co-Sponsor Sen. Paul Faraci
3/10/2023	Senate	Second Reading
3/10/2023	Senate	Placed on Calendar Order of 3rd Reading March 21, 2023
3/23/2023	Senate	Placed on Calendar Order of 3rd Reading ** March 24, 2023
3/29/2023	Senate	Third Reading - Passed; 057-000-000
3/30/2023	House	Arrived in House
3/30/2023	House	Chief House Sponsor Rep. Jennifer Gong-Gershowitz
3/30/2023	House	First Reading
3/30/2023	House	Referred to Rules Committee
4/11/2023	House	Assigned to Insurance Committee
4/17/2023	House	Added Alternate Co-Sponsor Rep. Janet Yang Rohr
4/18/2023	House	Do Pass / Short Debate Insurance Committee; 014-000-000
4/19/2023	House	Placed on Calendar 2nd Reading - Short Debate
4/27/2023	House	Second Reading - Short Debate
4/27/2023	House	Placed on Calendar Order of 3rd Reading - Short Debate
5/4/2023	House	Third Reading - Short Debate - Passed 104-000-000
5/4/2023	Senate	Passed Both Houses
6/2/2023	Senate	Sent to the Governor
6/9/2023	Senate	Governor Approved
6/9/2023	Senate	Effective Date June 9, 2023
6/9/2023	Senate	Public Act . . . . . . . . . 103-0059